Cargando…

Myostatin in the Pathophysiology of Skeletal Muscle

Myostatin is an endogenous, negative regulator of muscle growth determining both muscle fiber number and size. The myostatin pathway is conserved across diverse species ranging from zebrafish to humans. Experimental models of muscle growth and regeneration have implicated myostatin as an important m...

Descripción completa

Detalles Bibliográficos
Autores principales: Carnac, Gilles, Vernus, Barbara, Bonnieu, Anne
Formato: Texto
Lenguaje:English
Publicado: Bentham Science Publishers Ltd. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647158/
https://www.ncbi.nlm.nih.gov/pubmed/19412331
http://dx.doi.org/10.2174/138920207783591672
_version_ 1782164907076091904
author Carnac, Gilles
Vernus, Barbara
Bonnieu, Anne
author_facet Carnac, Gilles
Vernus, Barbara
Bonnieu, Anne
author_sort Carnac, Gilles
collection PubMed
description Myostatin is an endogenous, negative regulator of muscle growth determining both muscle fiber number and size. The myostatin pathway is conserved across diverse species ranging from zebrafish to humans. Experimental models of muscle growth and regeneration have implicated myostatin as an important mediator of catabolic pathways in muscle cells. Inhibition of this pathway has emerged as a promising therapy for muscle wasting. Here we discuss the recent developments and the controversies in myostatin research, focusing on the molecular and cellular mechanisms underlying the actions of myostatin on skeletal muscle and the potential therapeutic role of myostatin on muscle-related disorders.
format Text
id pubmed-2647158
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Bentham Science Publishers Ltd.
record_format MEDLINE/PubMed
spelling pubmed-26471582009-04-30 Myostatin in the Pathophysiology of Skeletal Muscle Carnac, Gilles Vernus, Barbara Bonnieu, Anne Curr Genomics Article Myostatin is an endogenous, negative regulator of muscle growth determining both muscle fiber number and size. The myostatin pathway is conserved across diverse species ranging from zebrafish to humans. Experimental models of muscle growth and regeneration have implicated myostatin as an important mediator of catabolic pathways in muscle cells. Inhibition of this pathway has emerged as a promising therapy for muscle wasting. Here we discuss the recent developments and the controversies in myostatin research, focusing on the molecular and cellular mechanisms underlying the actions of myostatin on skeletal muscle and the potential therapeutic role of myostatin on muscle-related disorders. Bentham Science Publishers Ltd. 2007-11 /pmc/articles/PMC2647158/ /pubmed/19412331 http://dx.doi.org/10.2174/138920207783591672 Text en ©2007 Bentham Science Publishers Ltd. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/) which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Carnac, Gilles
Vernus, Barbara
Bonnieu, Anne
Myostatin in the Pathophysiology of Skeletal Muscle
title Myostatin in the Pathophysiology of Skeletal Muscle
title_full Myostatin in the Pathophysiology of Skeletal Muscle
title_fullStr Myostatin in the Pathophysiology of Skeletal Muscle
title_full_unstemmed Myostatin in the Pathophysiology of Skeletal Muscle
title_short Myostatin in the Pathophysiology of Skeletal Muscle
title_sort myostatin in the pathophysiology of skeletal muscle
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647158/
https://www.ncbi.nlm.nih.gov/pubmed/19412331
http://dx.doi.org/10.2174/138920207783591672
work_keys_str_mv AT carnacgilles myostatininthepathophysiologyofskeletalmuscle
AT vernusbarbara myostatininthepathophysiologyofskeletalmuscle
AT bonnieuanne myostatininthepathophysiologyofskeletalmuscle